• Skip to primary navigation
  • Skip to main content
  • Skip to footer

SunCoast Optimal Wellness

Your Wellness Partners

  • Home
  • Services
    • Medical Services
    • Wellness Services
  • About Us
    • Our Team
    • Frequently Asked Questions
    • Testimonials
  • Contact Us
  • Blog
  • Our Favorites
  • Free Consultation

Semaglutide: Benefits & More Information

February 27, 2023 by SunCoast Optimal Wellness

There has been a lot of talk about the new weight loss drug, Semaglutide, and the benefits that it provides to patients in their weight loss journey. Since this is included in our weight loss plan, we wanted to share more information about this type of treatment.

How Does Semaglutide (Wegovy) Work?

Wegovy works by mimicking a hormone called glucagon-like peptide-1 (GLP-1) that targets areas of the brain that regulate appetite and food intake. The medication dose must be increased gradually over 16 to 20 weeks to 2.4 mg once weekly to reduce gastrointestinal side effects.

FDA.gov

Benefits of Semaglutide

Semaglutide helps you lose weight safely since it works to suppress your appetite. This allows you to eat fewer calories and get into a calorie deficit without feeling hungry constantly. When most people start working towards losing weight, their appetite can really get in the way of progress, making this a great addition to their health plan.

Semaglutide also promotes the body’s use of insulin, which helps promote weight loss while also lowering your risk of developing type 2 diabetes. This is great for regulating your blood sugar, which helps to give you energy throughout the day.

This is also said to be a long-term weight loss solution as it continues to help regulate your appetite once you stop taking Semaglutide.

Studies of Semaglutide

Before approving Semaglutide, the FDA ran some tests, this is what they found:

The largest placebo-controlled trial enrolled adults without diabetes. The average age at the start of the trial was 46 years and 74% of patients were female. The average body weight was 231 pounds (105 kg) and average BMI was 38 kg/m2. Individuals who received Wegovy lost an average of 12.4% of their initial body weight compared to individuals who received placebo. Another trial enrolled adults with type 2 diabetes. The average age was 55 years and 51% were female. The average body weight was 220 pounds (100 kg) and average BMI was 36 kg/m2. In this trial, individuals who received Wegovy lost 6.2% of their initial body weight compared to those who received placebo. 

FDA

If you want to try Semaglutide, come book a weight loss appointment with us!

Filed Under: Uncategorized

Footer

Hours

Monday – Friday
9:30 am – 5 pm

Visit Us

230 Harbor Village Lane, Apollo Beach, FL 33572

Contact Us

(813) 645-2003

Connect With Us

Facebook
Pinterest
LinkedIn
LinkedIn
Share
Instagram
  • Privacy Policy
  • Terms of Use
2018-2026 SunCoast Optimal Wellness
This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Cookie settingsACCEPT
Privacy & Cookies Policy

Privacy Overview

This website uses cookies to improve your experience while you navigate through the website. Out of these cookies, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may have an effect on your browsing experience.
Necessary
Always Enabled
Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.
Non-necessary
Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.
SAVE & ACCEPT